Michael Hite, MBA Co-Founder and Chief Executive Officer
Mr. Hite’s experience in drug delivery systems ranges from product pipeline development through strategic business development, including relationship management with contract organizations. He is responsible for all business operations leading to the commercialization of the Pressurized Olfactory Delivery (POD) device technology.
John Hoekman, PhD Co-Founder and Chief Scientific Officer
Dr. Hoekman has focused on nasal drug delivery with an emphasis on delivery targeting the central nervous system using innovative device design and drug delivery systems. His research experience includes working with Dr. William Frey, one of the pioneers of nose-to-brain drug delivery, and Dr. Rodney Ho at the University of Washington. His unique background in both Physics and Pharmaceutics led to the development of Impel NeuroPharma’s core nasal delivery technology, the Pressurized Olfactory Delivery (POD) devices, of which he is co-inventor.